Literature DB >> 25808012

Algorithm-based multidisciplinary treatment approach for rectourethral fistula.

Deborah S Keller1, Sherif R Aboseif, Timothy Lesser, Mohammad Ali Abbass, Anna T Tsay, Maher A Abbas.   

Abstract

PURPOSE: The purpose of this study is to report the outcomes of an algorithm-based multidisciplinary treatment approach to rectourethral fistula.
METHODS: This study is a retrospective review of a prospectively collected database at a tertiary center of all consecutive patients treated between 2003 and 2013.
RESULTS: Thirty males (mean age 63 years) were reviewed. Prostate cancer treatment was the most common fistula etiology (97%). Urinary drainage consisted of urethral catheter in all patients and suprapubic catheter in 14 (47%). The rate of fecal diversion was 67%. During a mean follow-up of 72 months, healing rate was 90% and recurrence rate 0%. Spontaneous healing was achieved in 14 patients (47%): 8 (27%) without fecal diversion and 6 (20%) following fecal diversion. Thirteen patients (43%) required definitive intervention. The majority of operated patients underwent transanal or transperineal flap (endorectal, dartos, or gracilis) successfully. Only 2 patients (7%) required an abdominal approach (positive oncologic margins or non-functioning bladder). Fifteen out of the 20 patients (75%) who underwent fecal diversion had stoma closure with an overall permanent stoma rate of 17%. Long-term urinary incontinence was noted in 11 patients (37%). Six patients (20%) required permanent urinary diversion or drainage catheters.
CONCLUSIONS: Algorithm-based treatment approach for rectourethral fistula is useful in the management of this rare condition. Selective fecal diversion is possible, and majority of patients who require definitive intervention can be treated with a transanal or transperineal approach. The rate of permanent stoma is low, but long-term urinary dysfunction is frequent.

Entities:  

Mesh:

Year:  2015        PMID: 25808012     DOI: 10.1007/s00384-015-2183-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  33 in total

1.  Surgical management of rectourinary fistulae.

Authors:  P R Shin; E Foley; W D Steers
Journal:  J Am Coll Surg       Date:  2000-11       Impact factor: 6.113

2.  Experience with 30 posttraumatic rectourethral fistulas: presentation of posterior transsphincteric anterior rectal wall advancement.

Authors:  M al-Ali; D Kashmoula; I J Saoud
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

3.  Transperineal repair of complex rectourethral fistula using gracilis muscle flap interposition--can urinary and bowel functions be preserved?

Authors:  Gamal Ghoniem; Mostafa Elmissiry; Eric Weiss; Carolyn Langford; Hassan Abdelwahab; Steven Wexner
Journal:  J Urol       Date:  2008-03-18       Impact factor: 7.450

4.  Combined endorectal advancement flap with Alloderm graft repair of radiation and cryoablation-induced rectourethral fistula.

Authors:  Timothy Lesser; Sherif Aboseif; Maher A Abbas
Journal:  Am Surg       Date:  2008-04       Impact factor: 0.688

5.  Gracilis muscle transposition for iatrogenic rectourethral fistula.

Authors:  Oded Zmora; Fabio M Potenti; Steven D Wexner; Alon J Pikarsky; Jonathan E Efron; Juan J Nogueras; Victor E Pricolo; Eric G Weiss
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  Perineal subcutaneous dartos pedicled flap as a new technique for repairing urethrorectal fistula.

Authors:  A H Youssef; M Fath-Alla; A W El-Kassaby
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

7.  Bilateral puborectalis interposition repair of rectourethral fistula.

Authors:  Michael J Solomon; Ker-Kan Tan; Richard Gideon Bromilow; James C H Wong
Journal:  Dis Colon Rectum       Date:  2014-01       Impact factor: 4.585

8.  Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft.

Authors:  Alex J Vanni; Jill C Buckley; Leonard N Zinman
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

Review 9.  Rectal injury occurring at radical retropubic prostatectomy for prostate cancer: etiology and treatment.

Authors:  R H McLaren; D M Barrett; H Zincke
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

10.  The management of rectal injury during radical retropubic prostatectomy.

Authors:  R N Borland; P C Walsh
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

View more
  6 in total

Review 1.  Rectourethral Fistula Management.

Authors:  Daniel Ramírez-Martín; José Jara-Rascón; Teresa Renedo-Villar; Carlos Hernández-Fernández; Enrique Lledó-García
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

Review 2.  Management of acquired rectourethral fistulas in adults.

Authors:  Shulian Chen; Rang Gao; Hong Li; Kunjie Wang
Journal:  Asian J Urol       Date:  2018-01-31

3.  Urorectal fistula repair using different approaches: operative results and quality of life issues.

Authors:  Javier C Angulo; Ignacio Arance; Yannick Apesteguy; João Felicio; Natália Martins; Francisco E Martins
Journal:  Int Braz J Urol       Date:  2021 Mar-Apr       Impact factor: 1.541

4.  Lower Urinary Tract Symptoms in Prostate Cancer Patients Treated With Radiation Therapy: Past and Present.

Authors:  Whi-An Kwon; Seo-Yeon Lee; Tae Yoong Jeong; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2021-01-19       Impact factor: 2.835

5.  Post-traumatic rectourethral fistula in an adolescent managed via a transperineal approach using a local gluteal tissue interposition flap: a case report.

Authors:  Toshinori Hirano; Hiroki Ohge; Yusuke Watadani; Shinnosuke Uegami; Norimitsu Shimada; Ikki Nakashima; Kosuke Yoshimura; Shinya Takahashi
Journal:  Surg Case Rep       Date:  2021-12-16

6.  Management of Recurrent Rectourethral Fistula by York Mason Posterior Transrectal Transsphincteric Approach.

Authors:  Fahri Yetişir; A Ebru Şarer; H Zafer Acar; Omer Parlak; Gokhan Osmanoglu; Gulen Karalova
Journal:  Case Rep Urol       Date:  2015-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.